| CARD ID | 1992 | |
| Type of strain | Targeted mutant. | |
| Strain name | B6.129-Ptger2tm1Sna | |
| Internal Code | EP2KO | |
| Submitter | Narumiya Shuh | |
| Submitter affiliation or code | Innovation Center for Immunoregulation Technologies and Drugs, Kyoto University Graduate School of Medicine | |
| Stock Type | ||
| Material Transfer Conditions |
Consent to us
|
|
| Production method | in-house breeding | |
| Origin (In-house) | Organization | Kyoto University Graduate School of Medicine, Department of pharmacology |
| Organization code | Sna | |
| Developer | Shuh Narumiya | |
| Origin (From other organizations) | Organization | |
| Organization code | ||
| Developer | ||
| Year introduced | ||
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | Ptger2 |
| Gene name | prostaglandin E receptor 2 (subtype EP2) |
| Allele symbol | Ptger2tm1Sna |
| Allele name | prostaglandin E receptor 2, targeted mutation 1, Shuh Narumiya, Kyoto University |
| MGI | MGI:97794, |
| Chromosome | 14 (22.68) , |
| Gene classification | Targeted or trapped gene(knockout etc.) |
| Method | Electroporation |
| OMIM |
| Disease name, Applicable field | Physiology, Development, Immunology, cancer, Dermatology, Neurobiology |